Law360 (January 28, 2020, 2:22 PM EST) -- On Jan. 15, the United States and China announced an economic and trade deal, the "phase one" trade agreement, which could significantly improve the ability of U.S. and non-U.S. drug companies to protect their intellectual property rights and market their innovative pharmaceutical products in China.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Melanie
Contact Melanie, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack